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Regulatory T cells (T reg cells) are characterized 
by the expression of the forkhead lineage- 
specific transcription factor Foxp3 (Hori et al., 
2003). Studies performed in humans and animals 
indicate that CD4+ T reg cells play an important 
role in the prevention of autoimmune diseases 
and inflammation (Dubois et al., 2003; Bacchetta 
et al., 2006). These cells are critical for the main-
tenance of peripheral T cell tolerance because 
their depletion leads to autoimmune disorders 
(Sakaguchi, 2005; Kim et al., 2007). In addition 
to T reg cells, a wide range of APCs with regula-
tory function has been described. The best char-
acterized suppressive cells of myeloid origin are 
the  myeloid-derived  suppressor  cells  (MDSCs; 
Bronte et al., 2000; Nagaraj and Gabrilovich, 
2008). MDSCs are a heterogeneous cell popu-
lation  comprised  of  macrophages,  granulo-
cytes, and DCs at various stages of maturation 
(Serafini et al., 2006). Similar to T reg cells,   
MDSCs also display inhibitory properties toward 
T cells and other immune cells (Apolloni et al., 
2000). Increased numbers of MDSCs are as-
sociated  with  neoplastic,  inflammatory,  and   
infectious diseases, thereby suppressing the acti-
vation and expansion of immune responses 
(Talmadge, 2007). There are studies indicating 
that subpopulations of DCs can have regulatory 
properties capable of inducing peripheral tol-
erance (Zhang et al., 2004; Chung et al., 2005). 
For  example,  Hadeiba  et  al.  (2008)  demon-
strated that plasmacytoid DCs expressing CCR9 
were potent inducers of T reg cell function and 
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Regulatory T cells (T reg cells) are characterized by the expression of the forkhead lineage-
specific transcription factor Foxp3, and their main function is to suppress T cells. While 
evaluating T reg cells, we identified a population of Foxp3-positive cells that were 
CD11b+F4/80+CD68+, indicating macrophage origin. These cells were observed in spleen, 
lymph nodes, bone marrow, thymus, liver, and other tissues of naive animals. To characterize 
this subpopulation of macrophages, we devised a strategy to purify CD11b+F4/80+Foxp3+ 
macrophages using Foxp3-GFP mice. Analysis of CD11b+F4/80+Foxp3+ macrophage function 
indicated that these cells inhibited the proliferation of T cells, whereas Foxp3 macrophages 
did not. Suppression of T cell proliferation was mediated through soluble factors. Foxp3 
macrophages acquired Foxp3 expression after activation, which conferred inhibitory proper-
ties that were indistinguishable from natural Foxp3+ macrophages. The cytokine and tran-
scriptional profiles of Foxp3+ macrophages were distinct from those of Foxp3 macrophages, 
indicating that these cells have different biological functions. Functional in vivo analyses 
indicated that CD11b+F4/80+Foxp3+ macrophages are important in tumor promotion and the 
induction of T reg cell conversion. For the first time, these studies demonstrate the existence 
of a distinct subpopulation of naturally occurring macrophage regulatory cells in which 
expression of Foxp3 correlates with suppressive function.
© 2011 Zorro Manrique et al.  This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Currently, there are no defined cellular markers 
that can distinguish activator versus suppressor subpop-
ulations of MØ. Because MØs have regulatory proper-
ties that are found only under inflammatory conditions, 
it is unclear whether MØ could display regulatory 
function constitutively in the absence of inflammatory 
or polarizing stimuli. In the present studies, we have 
identified a previously uncharacterized naturally occur-
ring subpopulation of MØ (CD11b+F4/80+) that 
expresses Foxp3. Overall, our results indicate that 
CD11b+F4/80+Foxp3+ cells have immunoregulatory 
properties that inhibit T cells and contribute toward 
tumor progression. For the first time, these studies de-
scribe a previously unidentified population of naturally 
occurring CD11b+F4/80+Foxp3+ macrophage regu-
latory cells that may contribute to the regulation 
and maintenance of homeostatic balance of the 
immune system.
RESULTS
Identification of CD11b+Foxp3+ cells
During the course of our studies evaluating CD4+  
T reg cells, we observed a population of CD11b+ cells 
that expressed Foxp3 in spleen from C57BL/6 mice (Fig. 1 A). 
Further  evaluations  revealed  that  CD11b+Foxp3+  cells  were   
also present in bone marrow, thymus, lymph node, and liver 
(Fig. 1 A) and other organs such as lung and peripheral blood 
(not depicted). The CD11b+Foxp3+ cells represent 0.2–1% of 
the total number of cells in thymus, spleen and lymph nodes, 
whereas higher percentages were observed in bone marrow 
(5–6%) and liver (2–2.5%). To further define this CD11b+ 
Foxp3+ population, bone marrow, thymus, spleen, lymph node, 
and liver tissues were stained for F4/80 and CD68 cellular mark-
ers. CD11b+Foxp3+ cells were gated (Fig. 1 A, top right quad-
rant) and the expression of F4/80 and CD68 was analyzed. Our 
results show that >95% of the CD11b+Foxp3+ cells were posi-
tive for F4/80 and CD68 (Fig. 1 B), indicating that these cells 
are of MØ origin. We confirmed that CD4+ and CD8+ T cell 
populations express Foxp3; however, CD11c+ populations 
showed no expression of Foxp3 (Fig. 1 C). CD11b+F4/
80+Foxp3+ cells can be observed in bone marrow and spleen 
from RAG-1 KO mice (Fig. 1 D), confirming that these cells 
are of MØ origin and not a subpopulation of T cells.
suppressed antigen-specific immune responses both in vitro and 
in vivo. Another common subpopulation of immune cells with 
immune-suppressive functions is macrophages (MØ). Macro-
phages polarize according to activation stimuli and are classified 
into M1- and M2-MØ. M1-MØs are tumoricidal and pro-
mote tumor immunity, whereas M2-MØ promote angiogenesis, 
tumor progression, and tissue remodeling and inhibit immune 
responses (Mills et al., 2000; Martinez et al., 2008). Tumor- 
associated macrophages are a subpopulation of MØ regarded as 
critical cells for tumor progression that share many characteristics 
with M2-MØ (Allavena et al., 2008). Collectively, these data in-
dicate that various subpopulations of suppressive immune cells 
exist and are critical in regulating the immune responses and 
maintaining  the  homeostatic  balance  of  the  immune  system 
(Belkaid, 2007; Belkaid and Oldenhove, 2008; Mortellaro et al., 
2008; Mantovani et al., 2009). Furthermore, these subpopula-
tions of immune-suppressive cells also play a critical role in   
autoimmunity,  tumor  immunity,  organ  transplantation,  or 
microbial immunity (Belkaid, 2007; Belkaid and Oldenhove, 
2008; Mortellaro et al., 2008; Mantovani et al., 2009).
Figure 1.  Identification of CD11b+F4/80+Foxp3+ cells. 
Bone marrow, thymus, spleen, lymph nodes, and liver cells 
from C57BL/6 mice were stained with anti–CD11b-APC, anti–
Foxp3-FITC, anti–F4/80-PE, or anti–CD68-PE. (A) Percentages 
of double-positive CD11b/Foxp3 cells were determined.  
(B) CD11b+/Foxp3+-positive cells were gated, and expression of 
F4/80 and CD68 was determined. (C) Analysis of double-positive 
CD4/Foxp3, CD8/Foxp3, and CD11c/Foxp3 from spleen cells of 
C57BL/6 mice. (D) Percentages of double-positive CD11b/Foxp3 
cells were determined from bone marrow and spleen cells of 
RAG-1 KO mice. Positive CD11b+/Foxp3+ cells were gated and 
expression of F4/80 was determined. All data represent one of 
at least three separate experiments.JEM Vol. 208, No. 7 
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F4/80+Foxp3+  cells  were  of  MØ  origin  and 
have MØ function, morphological and phago-
cytic analyses were performed. As shown in   
Fig.  3 A,  single-sorted  F4/80+Foxp3+  and   
F4/80+Foxp3 cells have morphological char-
acteristics similar to those of MØ but clearly 
distinct from those of CD4+ T cells. To eval-
uate the phagocytic capacity of F4/80+Foxp3+ 
and F4/80+Foxp3 cells, they were incu-
bated with Alexa Fluor 700–labeled beads at 
different cell/bead ratios for 4 or 24 h. The 
data indicate that both F4/80+Foxp3+ and   
F4/80+Foxp3 cells have a similar capacity to 
phagocytose the beads, confirming that they are both of 
MØ origin (Fig. 3 B).
Phenotypic characterization of CD11b+F4/80+Foxp3+ cells 
from Foxp3-GFP mice
After sorting the Foxp3+ and Foxp3 MØ from bone mar-
row, we observed that the CD11b+Foxp3 cells were CD11bhi 
F4/80low, whereas CD11b+Foxp3+ cells were CD11blow 
F4/80hi (Fig. 4 A). T reg cells are characterized by the ex-
pression of cytotoxic T cell–associated antigen 4 (CTLA-4; 
Takahashi et al., 1998) and glucocorticoid-induced TNF   
receptor family-related gene/protein (GITR; Shimizu et al., 
2002), whereas MDSCs are defined by the expression of 
CD11b and GR-1 cellular markers. Recently, Gallina et al. 
(2006) showed that the presence of IL-4R on a subset   
of CD11b+ cells appeared to be critical for their suppres-
sive activity. Therefore, we stained for GR-1, CTLA-4, 
GITR, and IL-4R. Our results show that the percentage   
of  double-sorted  F4/80+Foxp3+  cells  expressing  GITR, 
IL-4R, and CTLA-4 is threefold higher compared with 
Isolation of CD11b+F4/80+Foxp3+ cells from Foxp3-GFP mice
Foxp3-GFP transgenic mice were used to isolate and charac-
terize CD11b+F4/80+Foxp3+ cells. Staining of bone marrow 
(Fig. 2 A) from Foxp3-GFP mice indicates that CD11b+F4/
80+CD68+GFP(Foxp3)+ cells are present in similar propor-
tions as in C57BL/6 mice. For functional in vitro analyses   
of CD11b+F4/80+GFP(Foxp3)+ cells, we devised a strategy 
where bone marrow (or spleen) cells from Foxp3-GFP mice 
were depleted of T and B cells and stained for CD11b and 
F4/80. CD11b+F4/80+ cells were gated (Fig. 2 B, fuchsia) 
and sorted based on the GFP-Foxp3 expression into Foxp3+ 
and Foxp3 cells (sorted MØ will be called F4/80+Foxp3 
or F4/80+Foxp3+). To further enrich and eliminate traces   
of any contaminating cells in the F4/80+Foxp3 and F4/
80+Foxp3+ populations, cells were sorted twice. The high 
purity of the two sorted populations was confirmed by flow 
cytometry (Fig. 2 B). Foxp3 levels were examined by PCR 
(Fig. 2 C), indicating that sorted F4/80+Foxp3+ cells, but   
not sorted F4/80+Foxp3 cells, express Foxp3 to the same 
degree as sorted CD4+Foxp3+ cells. To further confirm that 
Figure 2.  Isolation of CD11b+F4/80+Foxp3+ cells 
from Foxp3-GFP mice. (A) Percentages of double-
positive CD11b/GFP(Foxp3) cells and expression of 
F4/80 and CD68 were determined from bone marrow 
cells of Foxp3-GFP mice. 10 Foxp3-GFP mice were used 
to sort sufficient CD11b+F4/80+Foxp3+ cells. Data repre-
sent one experiment of at least 10 separate experi-
ments. (B) Bone marrow cells from Foxp3-GFP mice 
were stained with anti–CD11b-APC and anti–F4/80-PE. 
Positive CD11b+/F4/80+ cells were gated and first sorted 
for GFP(Foxp3)+ (85–90% purity) and GFP(Foxp3) 
(>95% purity) populations. Sorted CD11b+F4/
80+Foxp3 and CD11b+F4/80+Foxp3+ were resorted for 
a second time to enrich the populations, double-sorted 
GFP(Foxp3)+ (>98% purity), and double-sorted 
GFP(Foxp3) (100% purity). These levels of purity apply 
to all the further experiments. Data represent one ex-
periment of at least six separate experiments. (C) Evalu-
ation of Foxp3-mRNA expression from single-sorted 
F4/80+Foxp3, F4/80+Foxp3+, CD4+Foxp3 (>98% pu-
rity), and CD4+Foxp3 (>98% purity) cells. Data repre-
sent one experiment of at least five separate 
experiments. Error bars represent SE.1488 Characterization of Foxp3+ macrophages as regulatory cells | Zorro Manrique et al.
lack suppressive activity, whereas freshly 
isolated Foxp3+ T reg cells are inhibi-
tory. We investigated whether freshly 
isolated single- or double-sorted F4/80+ 
Foxp3+ MØ were naturally inhibitory. 
As shown in Fig. 5 A, single- or double-
sorted F4/80+Foxp3+ cells inhibited proliferation of the 
CD4+ T cells to the same degree as CD4+Foxp3+ T reg 
cells. In contrast, no inhibition was observed with F4/80+ 
Foxp3 cells. We confirmed that at a lower F4/80+Foxp3+ to 
CD4+ T cell ratio, the Foxp3+ MØs (single or double sorted) 
were still suppressive to the same degree as T reg cells (Fig. 5 B), 
which is compatible with physiological conditions. Because 
whole CD4+ T cells were used in the proliferation assays, and 
to rule out that the inhibition was not a result of the presence 
of T reg cells or that F4/80+Foxp3+ cells enhance the sup-
pressive function of T reg cells, the inhibitory capacity of 
F4/80+Foxp3+ cells was evaluated in 
the absence of  T reg cells. CD4+Foxp3 
T cells were sorted from Foxp3-GFP 
mice and co-cultured with single-sorted 
F4/80+Foxp3 or F4/80+Foxp3+ cells. 
The data indicate that F4/80+Foxp3+ 
double-sorted F4/80+Foxp3 cells (Fig. 4 B). Similar results 
were also observed in F4/80+Foxp3 (Fig. S1 A) or F4/80+ 
Foxp3+ (Fig. S1 B) cells from spleen. In contrast, both popu-
lations of F4/80+Foxp3 and F4/80+Foxp3+ cells expressed 
similar levels of GR-1.  These results indicate that F4/80+Foxp3+ 
and F4/80+Foxp3 cells differentially express cellular markers 
that might contribute to their function.
Suppressive characterization of F4/80+Foxp3+ cells
Previous studies have shown that freshly isolated CD11b+ 
Gr-1+ or CD11b+F4/80+ cells from naive animals typically 
Figure 3.  CD11b+F4/80+Foxp3+ cells 
have characteristics and function of  
macrophages. (A) Single-sorted F4/80+ 
Foxp3+ and F4/80+Foxp3 cells from bone 
marrow and CD4+ T cells from spleen were 
stained with Diff-Quick-Fixative for morpho-
logical analysis. The dotted lines indicate  
cells from different fields of the same smear 
preparation. Bars, 10 µm. Data represent one 
experiment of at least five separate experi-
ments. (B) 105 single-sorted F4/80+Foxp3+ 
and F4/80+Foxp3 cells were incubated  
with Alexa Fluor 700 beads at a 1:10, 1:25,  
or 1:50 cell/bead ratio for 4 h (left) or 24 h 
(right). At the determined times, cells were 
evaluated for the incorporation of beads by 
flow cytometry. Data represent one experi-
ment of at least three separate experiments.
Figure 4.  Phenotypic characterization of 
CD11b+F4/80+Foxp3+ cells from Foxp3-
GFP mice. (A) Expression of CD11b and F4/80 
was evaluated from bone marrow–derived 
double-sorted F4/80+Foxp3+ and F4/80+ 
Foxp3 cells. Data represent one experi-
ment of at least five separate experiments.  
(B) Double-sorted CD11b+F4/80+Foxp3+ and 
CD11b+F4/80+Foxp3 cells from spleen were 
stained using anti–GITR-Biotin, anti–IL-4R-
Biotin, anti–CTLA-4-Biotin, and anti–GR-1-
Biotin mAb plus Streptavidin–Alexa Fluor 700 
(black line). Control antibody, gray line. Data 
represent one experiment of at least five 
separate experiments.JEM Vol. 208, No. 7 
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for conferring suppressive capabilities 
to this subpopulation of MØ (Fig. 5 E). 
To evaluate whether factors secreted 
by F4/80+Foxp3+ cells could also have 
suppressive capacity, supernatants from 
single-sorted Foxp3+ and Foxp3 MØ were evaluated for 
their ability to inhibit the proliferation of CD4+ T cells. Our 
results indicate that only supernatants from Foxp3+ MØ in-
hibited the proliferation of CD4+ T cells (Fig. 6 A). To define 
which factor produced by F4/80+Foxp3+ cells inhibited the 
proliferation of T cells, supernatants from these cells were in-
cubated with neutralizing antibodies against IL-10, TGF-1, 
TGF-2, and prostaglandin E2 (PGE2). Our results show that 
only anti-PGE2 reverses the suppressive effect of the superna-
tant (Fig. 6 B), indicating that PGE2 is the inhibitory factor 
produced by F4/80+Foxp3+ cells. The levels of PGE2 secre-
tion from F4/80+Foxp3 and F4/80+Foxp3+ cells were eval-
uated. Our data indicate that F4/80+Foxp3+ cells secrete large 
cells, but not F4/80+Foxp3 cells, inhibited the proliferation 
of CD4+Foxp3 T cells (Fig. 5 C). These results confirm that 
Foxp3+ MØ are able to inhibit T cells in the absence of T reg 
cells. We also confirmed that F4/80+Foxp3+ cells, but not   
F4/80+Foxp3 cells, inhibited the proliferation of antigen-
activated CD4+ (OTII) and CD8+ (OTI) cells (Fig. S2, A and B). 
To validate that Foxp3 is critical in imparting immune- 
suppressive capabilities to CD11b+F4/80+ cells, the expres-
sion of Foxp3 was depleted in single-sorted F4/80+Foxp3+ 
cells by small interfering (si) RNA (Fig. 5 D). The results 
show that after depletion of Foxp3 expression in F4/80+ 
Foxp3+ cells, the cells lost their capacity to inhibit prolifera-
tion of T cells, confirming that Foxp3 is directly responsible 
Figure 5.  Evaluation of suppressive 
function of CD11b+F4/80+Foxp3+ cells.  
(A) To evaluate the suppressive activity of 
Foxp3+ and Foxp3 MØ, enriched CD4+ T cells 
(≥95% purity), and single- or double-sorted 
F4/80+Foxp3+ and F4/80+Foxp3, cells were 
co-cultured at a 1:1 ratio and proliferation of 
CD4+ T cells was measured. As a control, puri-
fied CD4+Foxp3+ cells (T reg cells) from Foxp3-
GFP mice were mixed at a 1:1 ratio with CD4+ 
T cells. One of at least five independent ex-
periments is shown. (B) To confirm the sup-
pressive capabilities of Foxp3+ MØ, CD4+  
T cells and single- or double-sorted F4/
80+Foxp3+ or CD4+Foxp3+ cells (T reg cells) 
were plated at different effector/suppressor 
ratios and proliferation of CD4+ T cells was 
measured. One of at least five independent 
experiments is shown. (C) CD4+Foxp3 cells 
(100% purity) were sorted from Foxp3-GFP 
mice and co-cultured with single-sorted  
F4/80+Foxp3+ or F4/80+Foxp3 cells at different 
cell ratios. Proliferation of CD4+ T cells was 
measured. One of three independent experi-
ments is shown. (D) Depletion of Foxp3 from 
F4/80+Foxp3+ cells by siRNA. Single-sorted 
CD11b+F4/80+Foxp3+ cells were transfected 
with Foxp3-siRNA and mRNA expression of 
Foxp3 was evaluated. CD4+Foxp3 and 
CD4+Foxp3+ cells were used as controls for 
Foxp3 expression. Vertical bars and lanes on 
the gels correspond to the same conditions. 
Data represent one experiment of at least 
three separate experiments. (E) Single-sorted 
F4/80+Foxp3+ cells were transfected with 
Foxp3-siRNA or control siRNA. After 48 h, 
cells were washed, mixed at a 1:1 ratio with 
CD4+ T cells, and proliferation of CD4+ T cells 
was measured. One of three independent 
experiments is shown. Error bars represent SE.1490 Characterization of Foxp3+ macrophages as regulatory cells | Zorro Manrique et al.
the proliferative capacity of double-sorted F4/80+Foxp3  
and  F4/80+Foxp3+  cells  after  stimulation  with  LPS.  F4/80+ 
Foxp3 and F4/80+Foxp3+ cells do not proliferate after cultur-
ing them in complete medium alone or in the presence of LPS 
(Fig. 7 B). These cells are only able to proliferate if they are in the 
presence of macrophage (M) CSF (Fig. 7 B). We also character-
ized the phenotype of the double-sorted induced F4/80+Foxp3+ 
cells (Fig. 7 C). As observed with the natural F4/80+Foxp3+ cells, 
induced F4/80+Foxp3+ cells expressed higher levels of GITR, 
IL-4R, and CTLA-4 compared with LPS-treated F4/80+Foxp3 
cells (Fig. 7 C), and no difference was observed in GR-1 expres-
sion. Furthermore, induced F4/80+Foxp3+ cells were able to   
inhibit the proliferation of CD4 T cells, whereas no significant 
inhibition  was  observed  with  LPS-treated  F4/80+Foxp3 
cells (Fig. 7 D). Collectively, these results demonstrate that   
induced F4/80+Foxp3+ cells behave similarly to naturally occur-
ring F4/80+Foxp3+ cells, paralleling the manner in which 
induced T reg cells behave like natural T reg cells.
Global transcriptional analysis of CD11b+F4/80+Foxp3  
and CD11b+F4/80+Foxp3+ cells
To further characterize and evaluate whether other biological 
differences exist between F4/80+Foxp3 and F4/80+Foxp3+ 
cells, gene expression profiles from these populations were 
studied. For these experiments, we used double-sorted F4/80+ 
Foxp3 and F4/80+Foxp3+ cells. We observed that 3,963 genes 
were differentially expressed (P = 0.05) by twofold or greater 
(full list of genes is in National Center for Biotechnology   
Information [NCBI] Gene Expression Omnibus [GEO] se-
ries accession no. GSE23793). Pathway enrichment analysis 
using MetaCore (pathway analysis software from GeneGo) 
amounts of PGE2, whereas the secretion of PGE2 by F4/
80+Foxp3 cells is minimal or nonexistent (Fig. 6 C). We 
wanted to assess whether F4/80+Foxp3+ cells induce suppres-
sion by cell–cell contact mechanisms. We used a transwell sys-
tem where single-sorted F4/80+Foxp3+ cells were added at 
the indicated ratios in the upper chamber, and purified CD4+ 
T cells were placed in the bottom chamber and stimulated 
with anti-CD3/anti-CD28 plus irradiated APCs. As shown in 
Fig. 6 D, T cell proliferation was substantially inhibited at the 
highest ratio (1:1) between Foxp3+ MØ/CD4+ T cells, and 
less inhibition was observed at lower ratios. These results indi-
cate that suppression was mediated by the secretion of soluble 
factors and is independent of cell-to-cell contact.
Induction of CD11b+F4/80+Foxp3+ from CD11b+F4/ 
80+Foxp3 cells
It is well established that CD4+ effector T cells that do not 
express Foxp3 can be induced to express Foxp3 by the addi-
tion of TGF- (Chen et al., 2003). Such induced T reg cells 
have the same capacity as natural T reg cells to inhibit other 
cells (Chen et al., 2003).  We evaluated whether F4/80+Foxp3 
cells could be converted to express Foxp3. Double-sorted 
F4/80+Foxp3 cells from bone marrow were incubated in 
the presence of LPS, CpG, TGF-, or vascular endothelial 
growth factor (VEGF) for 3 d. As shown in Fig. 7 A, the addi-
tion of LPS (42%), CpG (39%), TGF- (50%), and VEGF 
(43%) to the cultures induces the expression of Foxp3 in these 
cells. Similar results were observed in F4/80+Foxp3 cells 
from spleen samples (Fig. S3). To make sure that the de novo 
expression of Foxp3 is not the result of an expansion of a con-
taminating population of MØ-expressing Foxp3, we evaluated 
Figure 6.  CD11b+F4/80+Foxp3+ cells 
suppress by secretion of soluble factors. 
(A) Supernatants from cultured single-sorted 
F4/80+Foxp3+ and F4/80+Foxp3 cells were 
examined at different dilutions for inhibition 
of CD4+ T cell proliferation. Data represent 
one experiment of at least five separate ex-
periments. Error bars represent SE. (B) To 
identify which factor induces the inhibition of 
T cell proliferation, supernatants from single-
sorted F4/80+Foxp3+ cells were incubated 
with 10 µg/ml anti–IL-10, anti–TGF-1, anti–
TGF-2, anti-PGE2 mAb, and isotype control 
antibody for 2 h before the addition to the 
cultures. Proliferation of CD4+ T cells was 
evaluated. Each value represents the mean of 
triplicate wells ± SE. Proliferation data repre-
sent a single experiment of at least three 
independent experiments. (C) PGE2 secretion 
was evaluated from supernatants of single-
sorted F4/80+Foxp3+ and F4/80+Foxp3 cells. 
Each value represents the mean of triplicate 
wells ± SE. (D) To assess whether F4/80+Foxp3+ cells induce suppression by cell–cell contact mechanism, transwell assays were performed. Single-sorted 
F4/80+Foxp3+ cells were added at indicated ratios to the upper chamber, and purified CD4+ T cells were placed in the bottom chamber and stimulated 
with anti-CD3/anti-CD28 mAb plus irradiated APCs. Proliferation of CD4+ T cells was evaluated. Each value represents the mean of triplicate wells ± SE. 
Proliferation data are from a single experiment that is representative of at least three independent experiments.JEM Vol. 208, No. 7 
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compared with that of F4/80+FoxP3+ cells. There were 663 
genes expressed in both cell types (full list of genes is in GEO 
series accession no. GSE23793). The two salient pathways 
that these cells have in common are signaling through cyclic 
AMP (P = 8 × 105) and signaling through the TGF-R 
family (P = 1 × 104). This analysis illustrates that the pres-
ence of Foxp3 in two different immune cell types results in 
some concordance, as well as in significant differences in gene 
expression. The differences in basal gene expression between 
F4/80+FoxP3+ and F4/80+FoxP3 cells are an indication that 
these cells have different biological functions that affect the out-
come of the immune response. The data discussed in this pub-
lication has been deposited in NCBI GEO and are accessible 
through GEO series accession no. GSE23793 (http://www.ncbi 
.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23793).
Evaluation of cytokines, chemokines, and other factors 
produced by CD11b+F4/80+Foxp3 and CD11b+F4/ 
80+Foxp3+ cells
M1-MØs are characterized by the production of NO and are 
cytotoxic, whereas M2-MØs produce Arg, which facilitates 
resulted in a highly significant enrichment of genes encoding 
proteins involved in cytoskeletal remodeling (P = 2 × 106), 
adhesion (P = 4 × 106), metaphase checkpoint (P = 7 × 
106), and cell cycle regulation (P = 7 × 105) pathways. 
Genes in these pathways and other biologically relevant genes 
were grouped in five categories: chemokines, complement, 
cytokines, growth factors, and immunosuppression (Fig. 8). 
These  categories  highlight  significant  differences  between 
MØ and this new subpopulation of regulatory Foxp3+ MØ. 
Most  importantly,  the  microarray  analysis  confirmed  that 
genes related to immune suppression, such as Foxp3, Arg2, 
IL10, Tnfsfr18 (GITR), and others, were also up-regulated in 
Foxp3+ MØ. Indeed, GeneGo Metabolic Networks analysis 
identified the 1,2-didocosahexaenoyl-sn-glycerol-3-phosphate 
pathway, which leads to arachidonic acid (a PGE2 precursor) 
biosynthesis,  as  the  most  significantly  enriched  metabolic 
pathway (P = 2 × 107). This also corroborates our previous 
results showing heightened PGE2 production by these cells 
(Fig. 8). In addition, we examined the transcriptional similar-
ities between Foxp3+ MØ and T reg cells. A transcriptional 
profile of double-sorted natural T reg cells was generated and 
Figure 7.  Conversion of CD11b+ 
F4/80+Foxp3 cells. (A) Bone marrow–derived 
double-sorted F4/80+Foxp3 cells from 
Foxp3-GFP mice were plated at 5 × 105/well 
in 24-well plates in the presence of 1 µg/ml 
LPS, 1 µg/ml CpG, 5 ng/ml TGF-, and 5 ng/ml 
VEGF. Cells were cultured for 72 h and the 
expression of GFP (Foxp3) was analyzed. 
Untreated CD11b+F4/80+Foxp3 cells, dotted 
line. Data represent one experiment of at 
least five separate experiments. (B) Double-
sorted F4/80+Foxp3+ and F4/80+Foxp3 cells 
(105 cells/well) were incubated in complete 
medium alone, medium plus 1 µg/ml LPS, or 
medium plus 2 ng/ml M-CSF. Cells were in-
cubated for 3 d and proliferation was mea-
sured by 3H-Thymidine incorporation. Each 
value represents the mean of triplicate  
wells ± SE. Proliferation data are from a single 
experiment that is representative of at least 
three independent experiments. (C) Double-
sorted F4/80+Foxp3 cells from Foxp3-GFP 
mice were treated with 1 µg/ml LPS. After 72 h 
of incubation, cells were double-sorted  
into GFP(Foxp3) and GFP(Foxp3)+ cells. 
Double-sorted cells were evaluated for the 
level of expression of GR-1, CTLA-4, GITR, 
and IL-4 (thin line). Control antibody, dotted 
line. (D) Double-sorted LPS-F4/80+Foxp3 
and LPS-F4/80+Foxp3+ cells were plated at a 
1:1 ratio with enriched CD4+ T cells and pro-
liferation was measured. Each value repre-
sents the mean of triplicate wells ± SE. 
Proliferation data are from a single experi-
ment that is representative of at least three 
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conversion of Foxp3+ MØ is dose 
dependent and the conversion of large 
numbers  of  F4/80+Foxp3+  cells  re-
quires high concentrations of TGF- 
(Fig. S4). Overall, these results fur-
ther confirm that F4/80+Foxp3 and 
F4/80+Foxp3+ cells have significant 
differences in cytokine, chemokine, 
and growth factor profiles, suggest-
ing that these cells play different roles 
within the immune system.
Role of CD11b+F4/80+Foxp3+ cells 
in tumor promotion
We  analyzed  whether  the  F4/80+ 
Foxp3+ cells are found within a B16 
melanoma tumor model and whether 
this population is distinct from the 
MDSC (CD11b+Gr-1+) population. 
As expected, a large population of CD11b+ cells was found 
within the tumor. Of the CD11b+ population, only 2% of 
the  cells  were  F4/80+Foxp3+  and  10%  were  F4/80+, 
whereas the majority of the CD11b+ cells were GR-1+ 
(Fig. 10 A). These results demonstrate that different CD11b+ 
subpopulations can be found within a tumor and that they 
might serve different functions for tumor promotion or pro-
gression. We were surprised that only a small fraction of the 
CD11b+ cells were Foxp3+ within the tumor. We have 
previously demonstrated that T reg cells accumulate in this 
tumor over time (Sharma et al., 2008b). Therefore, we inves-
tigated whether F4/80+Foxp3+ cells accumulate within the 
tumor over time. Surprisingly, we observed that at earlier 
stages, when tumor volume is low (day 10), higher numbers 
of F4/80+Foxp3+ cells are present within the tumor com-
pared with the levels of CD4+Foxp3+ cells (Fig. 10 B). At 
later stages, when the tumor load is larger (30 d), the numbers 
of F4/80+Foxp3+ cells were lower compared with the levels 
of CD4+Foxp3+ cells (Fig. 10 B). These results suggest that 
F4/80+Foxp3+ cells might be critical at earlier stages of tu-
morigenesis or during tumor initiation. Several studies have 
indicated that MDSC and DCs are able to induce the conver-
sion of T reg cells (Huang et al., 2006; Yamazaki et al., 2008). 
tumor growth and progression (Mills, 2001). We investigated 
whether there were differences in the levels of Arg1 and in-
ducible NO synthase (iNOS) between F4/80+Foxp3 and 
F4/80+Foxp3+ cells. Our results indicate that higher percent-
ages of single-sorted F4/80+Foxp3+ cells were positive for 
Arg1, whereas both F4/80+Foxp3 and F4/80+Foxp3+ cells 
minimally expressed iNOS (Fig. 9 A).
The production of cytokines, chemokines, and growth 
factors secreted by F4/80+Foxp3 and F4/80+Foxp3+ cells 
was also studied (Fig. 9 B). Our results showed that dif-
ferences of at least twofold or more existed between F4/80+ 
Foxp3 and F4/80+Foxp3+ cells. F4/80+Foxp3 cells se-
creted more IL12(p40), IL12(p70), IL13, IL15, TNF, and 
TGF-1, whereas F4/80+Foxp3+ cells secreted more IL-1, 
CXCL2,  CCL4,  CXCL1,  VEGF,  and  platelet-derived 
growth factor (PDGF) BB. Interestingly, the basal levels of 
TGF-1  secreted  by  F4/80+Foxp3  cells  were  20-fold 
higher than those produced by F4/80+Foxp3+ cells. As shown 
in Fig. 7 A, TGF- induces the conversion of F4/80+Foxp3 
cells into Foxp3+ cells. Because F4/80+Foxp3 cells pro-
duce high levels of TGF-, it can be hypothesized that the   
production of TGF- by F4/80+Foxp3 cells could induce 
their conversion into Foxp3+ MØ. Our data indicate that the 
Figure 8.  Global transcriptional analy-
sis of CD11b+F4/80+Foxp3 and 
CD11b+F4/80+Foxp3+ cells. Heat maps 
showing five groups of gene categories 
derived from significantly enriched path-
ways (P < 0.001), illustrating major differ-
ences in gene expression levels between 
double-sorted F4/80+Foxp3+ and double-
sorted F4/80+Foxp3 cells. All genes are 
significantly (P = 0.05) differentially ex-
pressed with greater than or equal to two-
fold change. The color bar shows ranges 
from 4 to +4 on a log2 scale.JEM Vol. 208, No. 7 
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might be different between F4/80 KO and wild-type mice. 
There  are  no  previous  studies  indicating  whether  or  not 
F4/80 KO mice support tumor growth. This was tested by 
inoculating 106 B16 tumors into F4/80 KO mice. Our results 
showed that F4/80 animals did not develop tumors (Fig. 10 D). 
We do not fully understand why F4/80 KO mice do not 
support tumor growth. It is possible to speculate that the 
tolerogenic function of MØ is altered in these animals, that   
T reg cells are not induced in these animals, as indicated by 
Lin et al. (2005), or, because F4/80 is a molecule involved in 
adhesion, it might be important for cell–cell interaction func-
tion or migration. We took advantage of the F4/80 KO mice 
to investigate whether F4/80+Foxp3+ cells have a role in 
promoting tumor growth. For these experiments, B16 tumor 
cells were mixed at a 1:1 ratio with single-sorted F4/80+ 
Foxp3+ or F4/80+Foxp3 cells and implanted into F4/80 
KO mice. As shown in Fig. 10 D, in the presence of F4/80+ 
Foxp3+ cells, the tumor growth was restored almost to the 
same rate as the C57BL/6 mice. A mixture of B16 cells and 
F4/80+Foxp3 cells minimally promoted the tumor growth. 
To further evaluate whether F4/80+Foxp3+ cells are critical 
in  supporting  and  promoting  tumor  growth,  we  tested  a 
lower B16 cell to F4/80+Foxp3+ cell ratio (1:0.1). At this 
lower ratio, F4/80+Foxp3+ cells were superior than F4/80+ 
Foxp3 cells at a 1:1 ratio in promoting tumor growth 
(Fig. 10 D), indicating the importance of Foxp3+ MØ in   
tumor promotion. Similarly, Ehirchiou et al. (2007) also 
found that in CD11b KO mice peripheral tolerance cannot 
be induced in these animals. We analyzed whether CD11b 
KO mice support the tumor growth of B16 tumors. Our re-
sults demonstrated that similar to the F4/80 KO mice, these 
animals also did not develop tumors (Fig. S5). When B16 
cells were mixed with F4/80+Foxp3+ cells, tumors grew in 
CD11b KO mice but not with F4/80+Foxp3 cells (Fig. S5). 
It can be argued that F4/80+Foxp3+ cells are relevant in the 
F4/80 KO or CD11b KO mice because these animals might 
have a defect in the MØ compartment. Therefore, we wanted 
to evaluate the role of these cells in tumor development in 
normal mice. For this aim, we identified the minimum number 
of B16 cells that do not form tumor in C57BL/6 mice (1 × 105). 
Then, 1 × 105 B16 tumor cells were mixed at 1:1 or 1:0.1 
ratios with F4/80+Foxp3+ or F4/80+Foxp3 cells and im-
planted into C57BL/6 mice. As shown in Fig. 10 E, F4/80+ 
Foxp3+ cells at a 1:1 or a 1:0.1 ratio rescued the formation of 
tumors, whereas F4/80+Foxp3 cells did not. These results 
further support the notion that one of the roles of F4/80+ 
Foxp3+ cells is to promote tumor growth.
DISCUSSION
For the first time, we report a unique population of CD11b+ 
F4/80+ (and CD68+) cells that express Foxp3, suggesting that 
these cells are of MØ origin. Our results are in agreement 
with the findings from Zuo et al. (2007) indicating that Foxp3 
has a broad function outside of T reg cells in which Foxp3 
could be expressed in epithelial cells of multiple organs (Chen 
et al., 2008) or, as indicated from our studies, in other immune 
We examined whether F4/80+Foxp3+ cells induce de novo 
conversion of T reg cells. To avoid the possibility that con-
taminating CD4+Foxp3+ cells were present in the cultures 
and expanded by the presence of F4/80+Foxp3+ cells, we 
used the Foxp3–Diphtheria toxin (DT) receptor (DTR) mice 
for these experiments. Foxp3-DTR mice were treated with 
50 µg/kg DT (Johanns et al., 2010). Under these conditions, 
>99% of the T reg cells were depleted in the periphery and 
spleen (Fig. 10 C, inset). CD4+Foxp3 T cells were sorted 
from DT-treated Foxp3-DTR mice and co-cultured in the 
presence of double-sorted F4/80+Foxp3 or F4/80+Foxp3+ 
cells. Our results indicate that co-culture of F4/80+Foxp3+ 
cells and CD4+Foxp3 cells resulted in de novo conversion 
of T reg cells (Fig. 10 C), whereas no conversion was ob-
served in the presence of F4/80+Foxp3 cells (Fig. 10 C). Based 
on  these  results,  we  wanted  to  establish  whether  F4/80+ 
Foxp3+ cells are involved in promoting tumor growth. Lin 
et al. (2005) demonstrated that F4/80 KO mice have normal 
development and distribution of MØ; however, in these ani-
mals it is not possible to induce peripheral tolerance. Because 
the lack of F4/80 had been implicated in peripheral toler-
ance, we speculated that perhaps the rate of tumor growth 
Figure 9.  Analysis of cytokine profiles of CD11b+F4/80+Foxp3+ 
and CD11b+F4/80+Foxp3 cells. (A) The level of Arginase 1 and iNOS 
expression (thin line) in single-sorted F4/80+Foxp3 and F4/80+Foxp3+ 
cells was evaluated by flow cytometry. Control antibody, dotted line.  
Data represent one experiment of at least three separate experiments.  
(B) Single-sorted F4/80+Foxp3+ and F4/80+Foxp3 cells were cultured for 
3 d in complete medium supernatants collected and the levels of cytokines, 
chemokines, and growth factors were analyzed by multiplex assay. Each 
value represents the mean of triplicate wells ± SE.1494 Characterization of Foxp3+ macrophages as regulatory cells | Zorro Manrique et al.
Figure 10.  CD11b+F4/80+Foxp3+ cells promote tumor growth. (A) A 30-d-old B16 tumor was stained with anti–CD11b-APC, anti–Foxp3-FITC, and 
anti–F4/80-PE or anti–GR1-PE mAb. CD11b+ cells were gated and percentages of CD11b+Foxp3+ cells were determined. Percentages of double-positive 
CD11b/F4/80 or CD11b/GR-1 cell were determined from the gated CD11b+/Foxp3+ cells and CD11b+/Foxp3 cells. Data shown are from a single experiment 
that is representative of at least three independent experiments. (B) C57BL/6 mice were inoculated with 1 × 106 B16 cells and animals were sacrificed on 
day 10, 20, or 30. The absolute numbers of CD11b+F4/80+Foxp3+ and CD4+Foxp3+ cells within the tumor was evaluated. Five animals were included per 
group. Data are representative of two experiments. (C) Foxp3-DTR mice were treated with 50 mg/kg DT for 2 d. On day 3, animals were sacrificed. With 
this protocol, >99% of the T reg cells were depleted in spleen (inset). After treatment, CD4+Foxp3 cells from Foxp3-DTR mice were sorted and plated on 
plates coated with anti-CD3 antibody and anti-CD28 antibody and co-cultured in the presence of double-sorted F4/80+Foxp3 or F4/80+Foxp3+ cells at 
different CD4+Foxp3 cell to F4/80+Foxp3/+ cell ratios. After 3 d of incubation, percentages of converted CD4+Foxp3+ were analyzed. One of at least 
three independent experiments is shown. (D) C57BL/6 and F4/80 KO mice were implanted with 1 × 106 B16 cells. Single-sorted CD11b+F4/80+Foxp3+ cells 
from Foxp3-GFP mice (106 or 105) were mixed with B16 cells (106) and implanted s.c. into F4/80 KO mice and tumor growth was analyzed. In the control 
F4/80 KO group, mice were implanted with a mixture of 106 B16 cells and 106 single-sorted CD11b+F4/80+Foxp3 cells and tumor growth was evaluated. 
Five animals were included per group. Data are representative of two experiments. (E) 105 single-sorted F4/80+Foxp3± or 104 single-sorted F4/80+Foxp3+ 
cells from Foxp3-GFP mice, mixed with 105 B16 cells, were implanted s.c. into C57BL/6 mice and tumor growth was analyzed. As a control for tumor 
growth, C57BL/6 mice were implanted with 3 × 105 B16 cells. Five animals were included per group. Data are representative of two experiments. Error 
bars represent SE.JEM Vol. 208, No. 7 
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cells besides T cells. This newly identified population of 
Foxp3+ MØ is distributed in all major lymphoid organs. The 
presence  of  Foxp3+  MØ  in  RAG-1  KO  mice  that  lack   
T cells confirms that this population of Foxp3-positive cells 
is not of T cell origin. Additionally, morphological and phago-
cytic assays confirmed that F4/80+Foxp3+ cells have the 
characteristics and function of MØ. A major function of   
T reg cells is their ability to inhibit other cells. Our results 
showed  that  only  F4/80+Foxp3+  cells,  and  not  F4/80+ 
Foxp3 cells, were able to inhibit the proliferation of T cells 
to the same degree as CD4+Foxp3+ T reg cells. The suppres-
sive capabilities of F4/80+Foxp3+ cells did not depend on the 
presence of T reg cells. The expression of Foxp3 is critical to 
confer suppressive capabilities to F4/80+Foxp3+ cells because 
depletion of Foxp3 mRNA results in the inability of these cells 
to suppress T cell proliferation. Phenotypic characterization of 
F4/80+Foxp3+ cells revealed that these cells express lower levels 
of CD11b and higher levels of F4/80 compared with F4/80+ 
Foxp3 cells. It is not yet clear why the Foxp3+ cells express 
CD11b and F4/80 differentially. Several studies have demon-
strated that the level of F4/80 expression on MØ is associated 
with tolerogenic effector function (van den Berg and Kraal, 
2005). Lin et al. (2005) demonstrated that the F4/80 molecule is 
involved in the induction of immunological tolerance. Perhaps 
higher expression of F4/80 is associated with suppressive activity, 
as reported by Sica and Bronte (2007) and Kusmartsev and   
Gabrilovich (2005), where intratumoral Gr-1+ MDSC could 
mature into GR-1F4/80+ cells with immunosuppressive 
properties. Our results show that CTLA-4, GITR, and IL4R 
are differentially expressed between Foxp3+ and Foxp3 MØ. 
Regardless of the expression of these cellular markers, F4/80+ 
Foxp3+  cells  have  suppressive  capabilities  because  depletion   
of Foxp3 eliminated the inhibitory capacity of these cells. 
Although it has been demonstrated that MDSC-expressing 
IL4Rs are suppressive, it has been also demonstrated that MDSCs 
from IL4R KO mice are suppressive as well. Additionally, T reg 
cells can also have different levels of CTLA-4 and GITR expres-
sion, and all CD4+Foxp3+ T cells are still suppressive; hence, 
these results are compatible with ours. We still do not fully under-
stand the biological role of CTLA-4, GITR, and IL4R expres-
sion in this subpopulation of MØ; however, the expression of 
these cellular markers might be related with a state of activation/
maturation or these markers could be important in migration 
or other functions.
In  contrast  with  other  APCs  with  immune-regulatory 
properties that are induced under polarizing conditions such 
as infection or neoplastic diseases, a major characteristic of 
F4/80+Foxp3+ cells is that they are a natural occurring popu-
lation with suppressive capabilities. The main mechanism by 
which F4/80+Foxp3+ cells inhibit T cells is through secreted 
soluble factors because in Transwell assays, these cells could 
still suppress the proliferation of T cells. PGE2 is the main 
soluble factor used by F4/80+Foxp3+ cells for suppression. 
This  is  in  agreement  with  previous  studies  reporting  that 
monocytes  (Bryn  et  al.,  2008),  other  APCs  (Yang  et  al., 
2003), or T reg cells (Mahic et al., 2006) can suppress T cell 
function through the secretion of PGE2. These results show 
that PGE2 is a common mechanism used by the immune sys-
tem  to  maintain  homeostatic  balance  of  the  immune  re-
sponses. There is strong evidence that T reg cells could inhibit 
through contact-dependent mechanisms by inducing apop-
tosis of T cells (Pandiyan et al., 2007). Our microarray data 
points to differences in the expression of genes that are in-
volved in apoptosis induction of target cells. We examined 
the expression of several of these markers by FACS analysis. 
Our data indentified multiple molecules, such as TRAIL, 
CD200r, Lag3, B7-H1, B7-H4, and PD1, that are highly ex-
pressed in Foxp3+ MØ compared with Foxp3 MØ (unpub-
lished data). Therefore, it could be hypothesized that Foxp3+ 
MØ might regulate immune responses through the induction 
of cell death (under evaluation).
Our  results  also  demonstrate  that  F4/80+Foxp3  cells 
could be converted to express Foxp3, and these cells become 
phenotypically similar to natural F4/80+Foxp3+ cells with the 
capability to inhibit T cells. These cells can be converted using 
growth factors such as TGF-, VEGF, or toll-like receptor   
ligands (TLR-L). This could have important clinical ramifica-
tions because tumors secreting TGF- or VEGF may induce 
MØ to express Foxp3, potentially leading to the generation of 
an immunosuppressive environment and the promotion of   
tumor growth. This may apply also to infectious diseases where 
the presence of TLR-L might induce F4/80+Foxp3+ cells 
helping to control the immune responses. Future studies will 
determine the importance and biological role of induced   
F4/80+Foxp3+ cells in regulating immune responses. Overall, 
our results indicate that natural and induced F4/80+Foxp3+ 
cells have indistinguishable immune-regulatory properties.
Based on the transcriptome analysis, it is clear that Foxp3+ 
and Foxp3 MØ are distinct subpopulations of MØ that play 
different biological roles in the immune system. We observed 
that many genes involved in immune regulation are differen-
tially expressed between Foxp3+ and Foxp3 MØ. The high 
expression in Foxp3+ MØ of genes, such as Foxp3, IL-4R, 
Arg2, various phospholipases (Pla2g family), and others, cor-
relates strongly with immune-suppressive activity. Genes in-
volved in immune regulation, such as MAF and IGF1 which 
could drive a Th2 response and are capable of influencing the 
immune responses (Hunt and Eardley, 1986; Voice et al., 2004; 
Yamane et al., 2005), are highly up-regulated in Foxp3+ 
MØ. Genes involved in prostaglandin production (e.g., 
PTGS1 [cyclooxigenase-1], Pla2g4c, Plag5, and Pla2g6) are 
also up-regulated in Foxp3+ MØ, which correlates with the 
mechanism of inhibition used by these cells. Foxp3+ MØs 
also express a variety of growth factor genes (Fig. 8). It is pos-
sible that this palette of growth factors may contribute to the 
accelerated tumor growth and increased tumor volume seen 
in our in vivo analyses. One unexpected finding is that 
Foxp3+ MØs exhibit robust up-regulation of complement 
components (most by 60-fold; Fig. 8) and CD55 and CD59. 
These data strongly correlate with a recent study indicating 
that complement promotes tumor growth by regulating 
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CD11b KO mice. In normal mice, when animals were im-
planted with low numbers of tumor cells they were not able 
to form tumors; however, when these low numbers of tumor 
cells were mixed with F4/80+Foxp3+ cells at 1:1 or 1:0.1   
tumor  cell/Foxp3+  MØ  ratios  tumors  developed.  Collec-
tively, these results suggest that F4/80+Foxp3+ cells might be 
critical at the initial step of tumor formation where they 
create  an  environment  that  favors  tumor  growth.  Most 
likely, F4/80+Foxp3+ cells promote tumor growth by con-
currently using the mechanisms described in this section. 
These studies demonstrated for the first time that the pres-
ence of F4/80+Foxp3+ cells is very important for tumor 
initiation and promotion. Perhaps immunotherapeutic strate-
gies directed to eliminate or block the function of these 
cells could be critical to impair tumor growth and prevent   
metastatic lesions.
Whether or not F4/80+FoxP3+ cells are more related 
to M2-MØ and F4/80+FoxP3 cells to M1-MØ needs to 
be defined (Martinez et al., 2008). Based on the cytokine 
assays and transcriptional profile, F4/80+FoxP3+ cells have 
some characteristics of M2-MØ, whereas F4/80+FoxP3 
cells resemble M1-MØ. It is important to emphasize that 
the distinction of M1 and M2 MØ is based on the type of 
stimuli to polarize these cells, whereas the F4/80+FoxP3+ 
cells identified in these studies are a naturally occurring 
population with immune-regulatory properties. Based on 
our in vitro and in vivo functional analyses, it is clear that 
F4/80+Foxp3 and F4/80+Foxp3+ populations have dif-
ferent biological functions.
In summary, these studies describe and characterize for 
the first time a distinct subpopulation of CD11b+F4/80+ MØ 
that  expresses  Foxp3. The  expression  of  Foxp3  confers  to 
these MØs the ability to inhibit T cells. Based on the immuno-
regulatory properties of CD11b+F4/80+Foxp3+ cells, we 
termed these cells Foxp3+ regulatory macrophages. Presently, 
we do not completely understand the biology of Foxp3+ regula-
tory macrophages and much remains to be elucidated about the 
pathological functions of these cells. Further studies will deter-
mine the role of Foxp3+ regulatory macrophages in tolerance, 
autoimmunity, tumor immunity, organ transplantation, allergy, 
and microbial immunity and how these cells can help in the 
maintenance of the homeostatic balance of the immune system.
MATERIALS AND METHODS
Mice. C57BL/6 mice were purchased from Harlan. RAG-1 KO mice were 
purchased from The Jackson Laboratory. The Foxp3-GFP knockin (Fontenot 
et al., 2005) and Foxp3-DTR (Kim et al., 2007) mice were obtained from   
A. Rudensky (Sloan Kettering, New York, NY). The F4/80 KO mice (Lin   
et al., 2005) were obtained from J. Stein-Streilein (Schepens Eye Research Insti-
tute, Boston, MA). Mice were maintained under specific pathogen-free con-
ditions in our animal facility, and experiments were performed under the 
approval of Institutional Animal Care and Use Committee of the Mayo Clinic.
Isolation of CD11b+F4/80+Foxp3+ cells. Organ samples from C57BL/6 
mice were stained with anti–CD11b-APC and anti–F4/80-PE mAb (eBio-
science) and intracellularly stained with anti–Foxp3-FITC (eBioscience). To 
isolate CD11b+F4/80+Foxp3+ cells from Foxp3-GFP mice, spleen or bone 
marrow cells were treated with biotin-labeled anti-CD2, anti-CD3, and 
Because  the  Foxp3  transcription  factor  defines  mouse   
T reg cells and is also highly expressed in this new regulatory 
MØ population, we investigated whether there is transcrip-
tional homology between these two regulatory cell popula-
tions. Our data indicates that many T reg cell–specific genes 
were also differentially expressed in Foxp3+ MØ. It has been 
suggested  that  mRNA  expression  of  heme  oxygenase  1 
(Hmox1 encoding HO-1) is linked to the induction of Foxp3 
in CD4+CD25+ T reg cells (El Andaloussi and Lesniak et al., 
2007). Our microarray data indicates that Hmox1 is >30-fold 
higher in Foxp3+ MØ than in Foxp3 MØ. Deaglio et al. 
(2007) demonstrated that coexpression of CD39 and CD73 
provide suppressive capabilities to T reg cells. The microarray 
data indicate that CD39 (Nt5e) and CD73 (Entpd1) are ex-
pressed  more  than  sixfold  higher  in  Foxp3+  MØ  than  in 
Foxp3 MØ but similar to levels in T reg cells. These are ex-
amples indicating some transcriptional concordance between 
T reg cells and Foxp3+ MØ, confirming the link between 
Foxp3 expression and suppressive capacity. Further studies will 
be necessary to unravel the precise role of genes that are differ-
entially regulated in F4/80+Foxp3 and F4/80+Foxp3+ popu-
lations and how they relate to the function of Foxp3+ MØ.
Based on the type of cytokines and other factors secreted 
by F4/80+Foxp3+ cells, we believe that these cells are associ-
ated with suppression, induction of immune-suppressive net-
works, and tumor promotion. F4/80+Foxp3+ cells produce 
more Arg-2, IL-1, CXCL4, CCL7, CCL9, CXCL12, 
CXCL13, PDGF, and VEGF. Arginase promotes tumor 
growth and progression (Bronte and Zanovello, 2005). Secre-
tion of IL-1 usually correlates with tumor invasiveness and a 
poor prognosis (Castrilli et al., 1997). CXCL4 down-regulates 
IFN- production and promotes the secretion of Th2 cyto-
kines (Romagnani et al., 2005). CXCL12 and CXCL13 play 
a key role in the trafficking of hematopoietic cells but are also 
involved in tumor growth and metastasis (Müller et al., 2001). 
CXCL9 can promote tumor escape and facilitates tumor 
metastases (Amatschek et al., 2011). CCL7 and CCL9 are 
chemoattractants responsible for recruiting MDSC (Kitamura 
et al., 2007; Sawanobori et al., 2008). VEGF is a major factor 
that promotes tumor angiogenesis. Additionally, VEGF could 
increase the number of immature DCs and accumulation of 
MDSC (Gabrilovich and Nagaraj, 2009) at the tumor site. 
PDGF-BB is overexpressed in various tumors such as pancreas, 
breast, ovarian, and others (Markiewski et al., 2008), and it 
is thought that PDGF-BB is involved in tumor formation 
by promoting angiogenesis and recruiting and activating 
stromal cells (Markiewski et al., 2008). This indicates that   
F4/80+Foxp3+ cells could use multiple mechanisms to pro-
mote tumor growth: (1) secreting growth and suppressive fac-
tors; (2) promoting the conversion of T reg cells; (3) inducing 
networks of immune suppression; and (4) directly inhibiting   
effector cells. Our data indicate that higher numbers of   
F4/80+Foxp3+ cells are found at early stages during the pro-
gression of tumor compared with T reg cells. Importantly, 
F4/80+Foxp3+ cells restored the growth of B16 tumors even 
at low tumor cell/Foxp3+ MØ ratios in F4/80 KO and JEM Vol. 208, No. 7 
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anti–GITR-Biotin,  and  anti–IL-4R-Biotin  and  then  incubated  with   
Streptavidin–Alexa Fluor 700 (eBioscience) and analyzed by flow cytometry. 
To evaluate, arginase and iNOS antibodies were purchased from BD.
Conversion  analysis.  1  ×  105  bone  marrow–derived  double-sorted 
CD11b+F4/80+Foxp3 cells from Foxp3-GFP mice were cultured in 24-well 
plates in complete medium in the presence or absence of 1 µg/ml LPS, 1 µg/ml 
CpG, 5 ng/ml TGF-, or 5 ng/ml VEGF. After 3 d of incubation, cells were 
harvested and stained with anti–CD11b-APC mAb and anti–F4/80-PE mAb. 
The induction of Foxp3(GFP) expression was analyzed by flow cytometry.
Multiplex assay. Bone marrow single-sorted CD11b+F4/80+Foxp3+/ popu-
lations were cultured in complete medium for 48 h and supernatants collected. 
The levels of cytokines and chemokines were assayed using multiplex lumines-
cent beads (Invitrogen) as described previously (Sharma et al., 2008a). The lower 
limit of detection was 1.5 pg/ml for each cytokine or chemokine.
Expression microarray analysis. RNA was isolated from CD11b+F4/
80+Foxp3+/ as well as from CD4+Foxp3+/ populations from three indepen-
dently double sorted cell harvests, using RNeasy min columns (QIAGEN), 
according to the manufacturer’s instructions. RNA was measured with the 
NanoDrop 1000 (Thermo Fisher Scientific) and its integrity verified with 
the Bioanalyzer 2100 (Agilent Technologies). 500 ng RNA per sample was 
labeled  using  the  low-input  linear  amplification  kit,  one  color  (Agilent 
Technologies). Dye incorporation and amplified RNA yield were measured 
with the NanoDrop. 1.65 µg of each cy3-labeled sample was hybridized to a 
4X44K mouse whole genome slide (Agilent Technologies), washed, and 
feature extracted according to the manufacturer’s (Agilent Technologies) in-
structions for single channel experiments. All experiments passed quality 
control metrics with a mean correlation coefficient between replicates of 
0.97  for  CD11b+F4/80+FoxP3+  arrays,  0.94  for  CD11b+F4/80+FoxP3  
arrays, 0.99 for CD4+Foxp3+ arrays, and 0.92 for CD4+Foxp3 arrays. Data 
analysis was done using GeneSpring GX11 software (Agilent Technologies), 
using default data normalization settings for single channel Agilent arrays. In 
brief, for each matched pair, low expressers and spots flagged as absent were 
removed in three of the six samples, followed by a Student’s t test (with a 
cutoff of P = 0.05) to retain only genes that are statistically differentially ex-
pressed, and finally a twofold change minimum between the two popula-
tions was applied to retain genes with significant changes in gene expression. 
The biological replicates were averaged and differential gene expression was 
expressed in log2. The data discussed in this publication has been deposited 
in National Center for Biotechnology Information’s Gene Expression Omnibus, 
and is accessible through GEO series accession no. GSE23793 (http://www 
.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23793)
Tumor growth analysis. C57BL/6 mice were implanted with 106 B16 
cells and animals were sacrificed on days 10, 20, and 30, and the levels of 
CD11b+F4/80+Foxp3+ and CD4+Foxp3+ cells were analyzed. 106 or 105 
single-sorted CD11b+F4/80+Foxp3+/ cells were mixed with 106 B16 cells 
and implanted s.c. into F4/80 KO mice and tumor growth was analyzed.
Statistics. Statistical comparisons between two experimental groups were 
made with a paired Student’s t test using InStat Software (GraphPad Soft-
ware). P-values <0.05 were considered significant.
Online  supplemental  material.  Fig.  S1  shows  phenotypic  characteriza-
tion of single-sorted F4/80+Foxp3+ and F4/80+Foxp3 cells from spleens of 
Foxp3-GFP mice. Fig. S2 demonstrates suppressive function of single-sorted   
F4/80+Foxp3+ cells against antigen-specific T cells. Fig. S3 shows the conver-
sion of single-sorted F4/80+Foxp3 cells to Foxp3+ from spleen cells and their 
phenotypic characterization. Fig. S4 shows titration of TGF- for the induc-
tion of Foxp3+ MØ. Fig. S5 demonstrates that transferring of single-sorted 
F4/80+Foxp3+  cells  rescues  tumor  growth  in  CD11b  KO  mice.  Online 
supplemental material is available at http://www.jem.org/cgi/content/full/ 
jem.20100730/DC1.
anti-CD45R mAbs (BD) and then incubated with anti-biotin microbeads 
(Invitrogen) to deplete these populations. Samples were then double-stained 
with  anti–CD11b-APC  and  anti–F4/80-PE  mAb. The  CD11b+F4/80+ 
Foxp3  and  CD11b+F4/80+Foxp3+  cell  fractions  were  collected  using 
three-color sorting on a FACSAria (BD). In some experiments, CD11b+F4/
80+Foxp3 and CD11b+F4/80+Foxp3+ cells were sorted twice to enrich the 
populations and avoid contaminations from other populations. At least 10 
Foxp3-GFP mice were used per experiment to isolate sufficient numbers of 
CD11b+F4/80+Foxp3+ cells.
Phagocytosis  assays.  105  single-sorted  CD11b+F4/80+Foxp3  and 
CD11b+F4/80+Foxp3+ cells from bone marrow were incubated with Alexa 
Fluor 700 beads at 1:10, 1:25, or 1:50 cell/bead ratios for 4 or 24 h. At the 
determined times, cells were evaluated for the incorporation of beads by 
flow cytometry.
Suppression assay. CD4+ T cells from spleen were enriched (95–98% 
purity) by magnetic purification (Invitrogen) and plated at 105 cells/well 
alone or co-cultured with bone marrow–derived single- or double-sorted 
CD11b+F4/80+Foxp3 or CD11b+F4/80+Foxp3+ cells (1 × 105, 5 × 104, or 
2.5 × 104 cells/well) in a 96-well flat-bottom plate coated with 2 µg/ml anti-
CD3 antibody and 2 µg/ml anti-CD28 antibody. Proliferation was measured 
by 3H-Thymidine incorporation after 72 h of incubation.
Transwell assay. Transwell experiments were performed in 96-well plates 
with pore size 0.4 µM (Millipore). 1 × 105, 5 × 104, or 2.5 × 104 single-
sorted CD11b+F4/80+Foxp3+ cells were added in the upper chamber. 1 × 
105 freshly purified CD4+ T cells were cultured in the bottom chamber and 
stimulated with 2 µg/ml anti-CD3/anti-CD28 plus irradiated APCs. CD4+ 
T cells were plated in the bottom chamber without adding CD11b+F4/
80+Foxp3+ cells in the upper as a control of proliferation. After 72 h in cul-
ture, top chambers were removed and 3H-Thymidine was added directly to 
the responder CD4+ T cells in the bottom chambers of the original Trans-
well plate for the final 16 h of the assay.
FOXP3  gene  silencing  with  siRNA  treatment. Foxp3 siRNA and 
FITC-labeled control siRNA (Santa Cruz Biotechnology) was prepared as 
specified  by  the  manufacturer.  Using  single-sorted  F4/80+Foxp3+  and   
F4/80+Foxp3 cells from BM, transient transfections were performed using 
Lipofectamine 2000 (Invitrogen) at a concentration of 20 nM and verified by 
flow cytometry to visualize the FITC control siRNA . Cells were cultured 
for 48 h, at which time maximum silencing was observed. Then, the cells 
were used for quantitative RT-PCR and proliferation assay.
Quantitative RT-PCR verification of gene expression knockdown. 
Total  RNA  was  isolated  from  single-sorted  CD11b+F480+FOXP3+, 
CD11b+F480+FOXP3 (bone marrow), and T reg (spleen) cells with the 
RNeasy  mini  kit  (QIAGEN).  Reverse  transcription  was  done  using   
SuperScript III, and real-time PCR used Power SYBR Green PCR Master Mix 
(Applied Biosystems) on the ABI7000 platform. FOXP3 primers (foxp3 
forward, 5-TTGGCCAGCGCCATCTT-3; foxp3 reverse, 5-TGCCT-
CCTCCAGAGAGAAGTG-3) and GAPDH primers (GAPDH forward, 
5-ACCCAGAAGACTGTGGATGG-3;  GAPDH  reverse,  5-CACAT-
TGGGGGTAGGAACAC-3) were used to determine FOXP3 mRNA   
levels in each population.
PGE2 production. Analysis of PGE2 production was performed using an 
ELISA kit and protocol developed by Cayman Chemical. In brief, single-
sorted  CD11b+F4/80+Foxp3  or  CD11b+F4/80+Foxp3+  cells  (105  cells/
well) from bone marrow were cultured for 48 h in complete media. Cell cul-
ture supernatants were collected, filtered, and assayed for presence of PGE2.
Phenotypic  characterization  of  CD11b+F4/80+Foxp3+  cells.  Bone   
marrow–derived  double-sorted  CD11b+F4/80+Foxp3+/  cells  from  Foxp3-
GFP  mice  were  stained  with  anti–GR-1-Biotin,  anti–CTLA-4-Biotin, 1498 Characterization of Foxp3+ macrophages as regulatory cells | Zorro Manrique et al.
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